Inventor
ARORA NIDHI
US20 patents
⚠️ This page may combine multiple inventors who share the name “ARORA NIDHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
7 patentsUS10717745B2Jul 21, 2020
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV5 citations82
US12065446B2Aug 20, 2024
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV1 citations72
US11319329B2May 3, 2022
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV1 citations72
US10934310B2Mar 2, 2021
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV4 citations71
US10822348B2Nov 3, 2020
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV0 citations50
US10800792B2Oct 13, 2020
Inhibitors of Bruton's tyrosine kinase and method of their use
JANSSEN PHARMACEUTICA NV0 citations50
US10689396B2Jun 23, 2020
Inhibitors of Bruton's tyrosine kinase and methods of their use
JANSSEN PHARMACEUTICA NV0 citations50
ROCHE PALO ALTO LLC
4 patentsUS7495015B2Feb 24, 2009
Indazole derivatives and methods for using the same
ROCHE PALO ALTO LLC10 citations84
US7435731B2Oct 14, 2008
Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same
ROCHE PALO ALTO LLC11 citations83
US7566708B2Jul 28, 2009
Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitors
ROCHE PALO ALTO LLC0 citations41
US7601726B2Oct 13, 2009
Substituted pyrazolo[3,4-d]pyrimidines as p38 MAP kinase inhibitors
ROCHE PALO ALTO LLC0 citations40
MIRATI THERAPEUTICS INC
4 patentsUS11091495B2Aug 17, 2021
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC4 citations82
US11220509B2Jan 11, 2022
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC2 citations71
US12371435B2Jul 29, 2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11485738B2Nov 1, 2022
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC0 citations61